Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$116M Sell
1,210,527
-26,929
-2% -$2.58M 0.02% 492
2026
Q1
$128M Buy
1,237,456
+188,732
+18% +$21.4M 0.03% 464
2025
Q4
$106M Sell
1,048,724
-9,596
-0.9% -$1.04M 0.02% 479
2025
Q3
$130M Sell
1,058,320
-230,177
-18% -$28.6M 0.03% 428
2025
Q2
$155M Buy
1,288,497
+131,240
+11% +$17.5M 0.03% 445
2025
Q1
$170M Buy
1,157,257
+41,485
+4% +$6.33M 0.04% 409
2024
Q4
$181M Buy
1,115,772
+123,200
+12% +$20.2M 0.04% 377
2024
Q3
$162M Sell
992,572
-33,795
-3% -$5.01M 0.04% 395
2024
Q2
$140M Buy
1,026,367
+150,556
+17% +$20.9M 0.04% 381
2024
Q1
$134M Buy
875,811
+33,876
+4% +$5.06M 0.05% 371
2023
Q4
$120M Sell
841,935
-1,123
-0.1% -$150K 0.05% 387
2023
Q3
$110M Buy
843,058
+73,362
+10% +$11.1M 0.05% 380
2023
Q2
$122M Hold
769,696
0.06% 346
2023
Q1
$122M Buy
769,696
+875
+0.1% +$131K 0.06% 346
2022
Q4
$108M Sell
768,821
-146,422
-16% -$20.8M 0.06% 363
2022
Q3
$118M Buy
915,243
+13,879
+2% +$2M 0.07% 324
2022
Q2
$127M Sell
901,364
-26,560
-3% -$3.79M 0.07% 320
2022
Q1
$129M Buy
927,924
+23,843
+3% +$3.65M 0.06% 355
2021
Q4
$158M Buy
904,081
+18,891
+2% +$3.15M 0.06% 328
2021
Q3
$147M Sell
885,190
-72,858
-8% -$12.5M 0.06% 323
2021
Q2
$172M Buy
958,048
+17,830
+2% +$3.25M 0.07% 287
2021
Q1
$181M Sell
940,218
-28,873
-3% -$5.56M 0.08% 258
2020
Q4
$196M Buy
969,091
+70,709
+8% +$14.6M 0.09% 228
2020
Q3
$189M Sell
898,382
-81,662
-8% -$18.2M 0.1% 190
2020
Q2
$215M Sell
980,044
-3,301
-0.3% -$660K 0.13% 151
2020
Q1
$170M Sell
983,345
-4,989
-0.5% -$824K 0.12% 168
2019
Q4
$152M Buy
988,334
+73,714
+8% +$11M 0.09% 235
2019
Q3
$139M Buy
914,620
+195,661
+27% +$30.9M 0.09% 230
2019
Q2
$110M Buy
718,959
+33,485
+5% +$5.12M 0.08% 272
2019
Q1
$110M Buy
685,474
+10,996
+2% +$1.71M 0.08% 269
2018
Q4
$104M Sell
674,478
-47,449
-7% -$7.39M 0.09% 244
2018
Q3
$109M Sell
721,927
-142,036
-16% -$20.2M 0.08% 271
2018
Q2
$117M Buy
863,963
+35,395
+4% +$4.37M 0.09% 257
2018
Q1
$110M Buy
828,568
+285,337
+53% +$38.3M 0.09% 266
2017
Q4
$80.8M Buy
543,231
+8,773
+2% +$1.19M 0.07% 313
2017
Q3
$70.5M Buy
534,458
+45,110
+9% +$6.06M 0.06% 329
2017
Q2
$65.2M Buy
489,348
+10,946
+2% +$1.48M 0.06% 333
2017
Q1
$64.5M Buy
478,402
+34,978
+8% +$4.53M 0.07% 325
2016
Q4
$53.2M Sell
443,424
-8,703
-2% -$1.03M 0.06% 355
2016
Q3
$56.6M Sell
452,127
-44,324
-9% -$5.81M 0.06% 334
2016
Q2
$68.7M Buy
496,451
+27,252
+6% +$3.53M 0.08% 278
2016
Q1
$59.1M Sell
469,199
-139,861
-23% -$17.8M 0.07% 311
2015
Q4
$77.2M Sell
609,060
-113,529
-16% -$14.1M 0.09% 253
2015
Q3
$83.5M Sell
722,589
-1,760
-0.2% -$198K 0.09% 245
2015
Q2
$75.3M Sell
724,349
-7,621
-1% -$822K 0.07% 297
2015
Q1
$80.8M Sell
731,970
-15,278
-2% -$1.66M 0.08% 279
2014
Q4
$77.9M Buy
747,248
+14,669
+2% +$1.47M 0.07% 290
2014
Q3
$70.4M Buy
732,579
+16,975
+2% +$1.53M 0.07% 299
2014
Q2
$65.4M Buy
715,604
+56,692
+9% +$5.08M 0.07% 316
2014
Q1
$58M Buy
658,912
+155,137
+31% +$13.6M 0.06% 334
2013
Q4
$46.7M Buy
503,775
+43,900
+10% +$3.95M 0.05% 367
2013
Q3
$37.6M Buy
459,875
+5,179
+1% +$437K 0.05% 405
2013
Q2
$37.8M Buy
+454,696
New +$39.1M 0.05% 388

Other funds holding CLX

UBS AM's CLX Position: Q2 2026 in Review

UBS AM reduced its Clorox (CLX) stake by 2.2% in Q2 2026, selling an estimated $2.58M and leaving 1,210,527 shares worth $116M. The position accounts for 0.02% of the portfolio, ranked #492.

UBS AM first reported a position in CLX in Q2 2013 and has held it in 53 quarters since. The position peaked at $215M in Q2 2020. 1,039 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • UBS AM held 1,210,527 shares of Clorox worth $116M as of Q2 2026.
  • UBS AM sold 26,929 Clorox shares in Q2 2026, an estimated $2.58M.
  • Clorox made up 0.02% of UBS AM's portfolio in Q2 2026, its #492 holding.
  • UBS AM first reported a position in Clorox in Q2 2013 and has held it in 53 quarters since.
  • UBS AM's Clorox position peaked at $215M in Q2 2020.
  • 1,039 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.